MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Examining and contextualizing free-living heart rate using multiple wearable sensors: a potential approach for assessing autonomic dysfunction in Parkinson’s disease?

    FE. Godkin, K. van Ooteghem, K. Ehgoetz Martens, K. Weber, B. Cornish, K. Beyer, D. Olszewska, C. Fearon, A. Lang, R. Swartz, M. Masellis, B. Tan, J. Tung, A. Roberts, W. Mcilroy (Waterloo, Canada)

    Objective: To examine context-specific fluctuations in free-living heart rate (HR) across a week-long multi-sensor wear period in people with Parkinson’s disease (PD). Background: Non-motor symptoms,…
  • 2024 International Congress

    Medication Effects on Bradykinesia and Tremor in Parkinson’s Disease, Measured by Wearable Sensors

    R. Weijer, A. Szanto, V. Exadaktylos, J. van Hilten, D. Hepp (Leiden, Netherlands)

    Objective: To determine the responsiveness to the effects of medication of home based unsupervised wearable sensor assessed tests for the evaluation of bradykinesia and tremor…
  • 2024 International Congress

    Spinocerebellar ataxia type 2 (SCA2) and Seizures: Is There a Correlation?

    P. Bhatia, S. Kaur (Phoenix, USA)

    Objective: We describe 3 patients of SCA2 with seizures, a rare phenomenology. Background: Spinocerebellar ataxia (SCA) is a heterogenous group of autosomal dominant neurodegenerative ataxic…
  • 2024 International Congress

    NGS diagnosis rate in a combined cerebellar ataxia and spastic paraplegia series from southern Spain

    A. Adarmes Gómez, S. Jesús Maestre, D. Macias Garcia, F. Carrillo Garcia, L. Muñoz Delgado, P. Gómez Garre, P. Mir (Sevilla, Spain)

    Objective: To evaluate the diagnosis rate of Next Generation Sequencing (NGS) in a combined series of patients with progressive cerebellar ataxia (CA) and progressive spastic…
  • 2024 International Congress

    Expanding the Phenotype of a Novel Mutation in ELOVL4 and the Differential Diagnosis of the Hot Cross Bun Sign

    G. Olmedo Saura, C. Pont Sunyer, I. Navalpotro Gomez, S. Bernal Noguera, B. Rodriguez Santiago, D. Guisado-Alonso, J. Pagonabarraga, C. García Sánchez, J. Kulisevsky, J. Perez Perez (Barcelona, Spain)

    Objective: To describe the clinical and radiological characteristics of three independent families affected by SCA 34 due to a recently identified mutation in ELOVL4. Background:…
  • 2024 International Congress

    Progressive Apraxia of Speech as a Presenting Symptom of Spinocerebellar Ataxia Type 2

    A. Blazek, G. Meade, L. Jackson, R. Gavrilova, J. Stierwalt, J. Martinez-Thompson, J. Duffy, H. Clark, M. Machulda, J. Whitwell, K. Josephs, R. Utianski, H. Botha (Rochester, USA)

    Objective: To describe a spinocerebellar ataxia (SCA) presenting with progressive apraxia of speech (AOS), a previously undescribed SCA phenotype. Background: Spinocerebellar ataxia type 2 (SCA2)…
  • 2024 International Congress

    Spectrum of Non-HD Hereditary Chorea- Case Series from An Indian Movement Disorder Centre

    D. Radhakrishnan, R. Rajan, A. Das, D. Garg, M. Faruq, A. Sonakar, A. Saini, A. Aliyar, J. Parihar, F. Mustafa, E. Arunmozhimaran, S. S, A. Agarwal, A. Pandit, K. Kanojia, Y. Puri, M. Tripathi, A. Srivastava (New Delhi, India)

    Objective: To identify and characterize the hereditary chorea other than Huntington’s disease (HD) in an Indian movement disorder clinic. Background: Approximately 1-3% of HD phenotypes…
  • 2024 International Congress

    A Phase IIb Double-Blind Placebo-Controlled Randomized Cross-Over Clinical Trial of Sodium Oxybate in Isolated Focal Laryngeal Dystonia

    L. O'Flynn, A. Hamzehei Sichani, S. Frucht, A. Rumbach, N. Sharma, P. Song, A. Worthley, K. Simonyan (Boston, USA)

    Objective: A phase IIb double-blind, placebo-controlled, cross-over, randomized clinical trial of a single dose of sodium oxybate investigated the efficacy and safety of the drug…
  • 2024 International Congress

    Paroxysmal non-kinesigenic dyskinesia: atypical neurological presentation of Lyme neuroborreliosis

    I. Sarac, H. Sarac, F. Borovecki, Z. Kresic (Zagreb, Croatia)

    Objective: To describe unusaul case of paroxysmal non-kinesigenic dyskinesia due to Lyme neuroborreliosis in a elderly female patient. Background: Nervous system Lyme disease is common…
  • 2024 International Congress

    Ataxic-spastic gait: a form of presentation of DYT5/DYT-GCH1

    V. Mendes Ferreira, M. Magriço, B. Meira, P. Bugalho (Lisboa, Portugal)

    Objective: Describe a case of DYT5/DYT-GCH1 presenting with an ataxic-spastic gait Background: DYT5/DYT-GCH1 is an autosomal dominant disease typically characterized by lower limb dystonia starting…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley